← Sun Pharma Advanced Research Company Ltd Intrinsic Value & Fundamental Analysis

Sun Pharma Advanced Research Company Ltd Share Price Target & Forecast 2027–2036

Q: Will Sun Pharma Advanced Research Company Ltd share price increase tomorrow?

Sun Pharma Advanced Research Company Ltd share price median forecast is ₹221.06 for 2026-09-25, which is 7.31% higher than today’s price of ₹206.00. The 10-90% range is ₹204.32 to ₹238.78. Forecast confidence is 55.0%, with probability-up estimate of 9.8%. This estimate uses Getaka’s price-history, valuation-gap and volatility framework.

Q: Should I buy Sun Pharma Advanced Research Company Ltd stock now?

The current Getaka valuation framework assigns Sun Pharma Advanced Research Company Ltd a 'hold' research stance. Intrinsic value is ₹192.66 vs current price ₹206.00. This is model output, not personalised investment advice; any decision should also consider risk tolerance, investment horizon and portfolio context.

Explore the year-by-year forecast for Sun Pharma Advanced Research Company Ltd alongside its financial results and valuation. The estimates depend on the model assumptions; use the ranges and the evidence behind them when comparing scenarios.

Last Updated: 24 Sep 2026

The next market-day median forecast for Sun Pharma Advanced Research Company Ltd (2026-09-25) is ₹221.06 which is 7.31% higher than today’s share price of ₹206.00 with a 10–90% range of ₹204.32–₹236.90. The estimate uses available price history, volatility, trend behaviour and intrinsic value gap.

Interactive Share Price Forecast

Choose tomorrow, day after, weekly, monthly or custom trading-day horizons and adjust assumptions to view possible price ranges.

Scenario controls

Quick horizon

Uses trading-day intervals for short-term and long-term forecast views.

Custom trading days: 1

1 = next market day, 2 = day after, 21 ≈ one trading month.

Scenario

Scenario adjusts assumptions for cautious, normal or optimistic market conditions.

Range band

Wider bands show more uncertainty; narrower bands show central outcomes.

Volatility stress: 100%

Higher volatility widens the forecast range.

Intrinsic value influence: 100%

Higher influence gives more weight to intrinsic value in the forecast.

Target date--

Median forecast--

Expected return--

Selected range--

Chance of upside--

Confidence--

Horizon	Target date	Median forecast	Range	Return	Chance of upside

Forecast guide: Explore possible future price ranges using available price history, intrinsic value trend, volatility and valuation gap. Estimates update as fresh market and valuation data become available.

Sun Pharma Advanced Research Company Ltd – Investor Insights

Valuation StatusiCompares the stock's intrinsic value (calculated from fundamentals like earnings, book value, and growth) with the current market price (CMP). Undervalued = potential buying opportunity. Overvalued = the market may be pricing in too much optimism.

Fairly Valued

Intrinsic ₹201.31 vs CMP ₹206.00 (-2.3%)

Market RegimeiShows whether the stock is in an uptrend (bullish) or downtrend (bearish) based on its Exponential Moving Average (EMA). When price is above EMA → bullish momentum. Below EMA → bearish pressure. This affects how our model adjusts volatility and predictions.

▲ Bullish

Price/EMA: 1.231 · EMA(252): ₹167.40

VolatilityiMeasures how much the stock price swings. Low (<25%) = stable, predictable price movement. Moderate (25-40%) = normal for most stocks. High (>40%) = large daily swings, higher risk. The "recent trend" shows if volatility is currently increasing or decreasing compared to its historical average.

76.6% annualized

Risk: High · Recent trend: Rising (recent > historical)

Trend MemoryiThe Hurst Exponent measures whether price movements tend to continue (trending) or reverse (mean-reverting). Above 0.55 = momentum persists, recent trends likely to continue. Below 0.45 = price tends to snap back after big moves. Around 0.5 = random walk, past moves don't predict future direction.

Random walk

Hurst exponent: 0.544

Projected CAGRiCompound Annual Growth Rate — the average yearly return if the stock reaches our projected price target. 5Y and 10Y show different time horizons. Higher CAGR = faster expected growth. Negative CAGR = the model projects the stock may decline from current levels.

-1.1% 5Y -0.9% 10Y

Historical drift: -2.9% annualized

Risk-Reward RatioiCompares your potential upside (to intrinsic value) against potential downside (to fundamental floor). Above 2x = favorable risk-reward, potential gain is at least double the potential loss. Below 1x = unfavorable, you risk losing more than you could gain. A negative value means the stock is already above intrinsic value.

-0.02x

Upside -2.3% vs downside 98% · Unfavourable

Margin of SafetyiA concept from value investing (Benjamin Graham). It measures how much cheaper the stock is compared to its intrinsic value. Positive margin = you're buying below fair value (safety cushion). Negative margin = you're paying more than the stock is fundamentally worth. Most value investors look for at least 15-25% margin of safety.

-2.3%

No margin

Forecast ConfidenceiShows how strongly the forecast is supported by available data, recent forecast behaviour and volatility. Higher confidence means the estimate has better historical support and lower uncertainty.

Moderate (55.0%)

Chance of upside: 9.8% · Avg forecast error: 14.65% · 535 data points

Fundamental FlooriA modelled fundamental reference level based on book value and financial-strength inputs (including ROE, ROCE and debt ratios). It is not a guaranteed price floor: market prices can trade below it when fundamentals change or during stressed conditions.

₹4.12

(98% below CMP)

52-Week Range

iShows the stock's lowest and highest closing prices over the past year (~252 trading days). The marker shows where today's price sits within that range. Near the low = potential value opportunity or ongoing weakness. Near the high = momentum or possible overextension.

₹109.00

₹239.00

CMP: ₹206.0075% into range13.8% below 52W high

Monthly Return DistributioniBased on historical monthly returns (~21 trading days per month). Shows how many months the stock went up vs down, the best and worst single-month returns, and the win rate. A win rate above 55% with a positive average return indicates consistent performance. High best/worst spread = volatile returns.

▲ 12 months up (48%)▼ 13 months down

Avg: +1.50%/moBest: +70.7%Worst: -26.3%Months analysed: 25

Convergence TimelineiShows a possible timeline for the stock price to move closer to its intrinsic value. Milestones show estimated prices at 25%, 50%, 75% and 100% convergence. For overvalued stocks, convergence may indicate downside toward intrinsic value.

Target: ₹201.31 in ~5.0 years (2031)

Now
₹20625%
₹20550%
₹20475%
₹202Target
₹201

Gap: 2.3% downward · Assumed convergence period: 5.0 years

What this means: Sun Pharma Advanced Research Company Ltd is trading near fair value. The stock is currently in a bullish regime (price above EMA). Volatility is high (76.6% annualized), implying wider price swings and higher risk.

Sun Pharma Advanced Research Company Ltd Year-Wise Share Price Target (2027–2036)

Year

Projected Price (₹)

Growth %

CAGR

2027

199.29

-3.3%

2028

196.12

-4.8%

-2.4%

2029

189.74

-7.9%

-2.7%

2030

199.83

-3.0%

-0.8%

2031

195.17

-5.3%

-1.1%

2032

177.29

-13.9%

-2.5%

2033

177.33

-13.9%

-2.1%

2034

173.43

-15.8%

-2.1%

2035

187.57

-8.9%

-1.0%

2036

187.48

-9.0%

-0.9%

Sun Pharma Advanced Research Company Ltd Stock Price Analysis

Avg Error (MAPE)iMean Absolute Percentage Error — the average difference between predicted and actual prices, expressed as a percentage. Lower is better. Below 2% = excellent, 2-5% = good, above 5% = the model struggles with this stock.

6.35%

Direction AccuracyiHow often the model correctly predicted whether the price would go up or down the next day. Above 55% = good (better than a coin flip). Above 60% = strong. This matters more than exact price accuracy for trading decisions.

56.4%

Avg Error (₹)iThe average rupee difference between predicted and actual closing prices. For a ₹100 stock, an error of ₹2 means predictions are typically off by about 2%. This gives you a sense of the prediction's precision in absolute terms.

₹9.41

PredictionsiTotal number of daily forecasts available for this stock. More observations improve the reliability of accuracy metrics and trend comparison.

243

View period

Chart layers Actual price Predicted price Error % line Prediction dates only

Selected period: MaxMAPE: 6.35%Direction: 56.4%Avg error: ₹9.41Forecast points: 243

Sun Pharma Advanced Research Company Ltd – Historical Performance vs Predictions

Sun Pharma Advanced Research Company Ltd – 3-Month Price Forecast

90-day target: ₹202.78|Range: ₹136.25 – ₹301.81|By: 23 Dec 2026

Sun Pharma Advanced Research Company Ltd Next Market-Day Share Price Probability Distribution

Median forecast: ₹221.06 · Expected range: ₹204.32 – ₹236.90 · Chance of upside: 9.8%

Sun Pharma Advanced Research Company Ltd Share Price Target – Frequently Asked Questions

Will Sun Pharma Advanced Research Company Ltd share price increase on the next market day?

Sun Pharma Advanced Research Company Ltd median forecast is ₹221.06 on 2026-09-25, which is 7.31% higher than today’s price of ₹206.00. The 10-90% forecast range is ₹204.32 to ₹236.90. Forecast confidence is 55.0%, with probability-up estimate of 9.8%. This estimate uses Getaka’s price-history, valuation-gap and volatility framework.

What is the intrinsic value of Sun Pharma Advanced Research Company Ltd?

Sun Pharma Advanced Research Company Ltd intrinsic value is ₹201.31, which is 2.28% below the current price of ₹206.00. This suggests the stock is currently fairly valued.

What is the share price target of Sun Pharma Advanced Research Company Ltd in 2027?

Sun Pharma Advanced Research Company Ltd share price target for 2027 is projected to reach ₹199.29 by year-end (range: ₹199.29 to ₹208.44), representing a -3.26% decrease from the current price of ₹206.00.

What is the share price target of Sun Pharma Advanced Research Company Ltd in 2028?

Sun Pharma Advanced Research Company Ltd share price target for 2028 is projected to reach ₹196.12 by year-end (range: ₹192.84 to ₹198.30), representing a -4.80% decrease from the current price of ₹206.00.

What is the share price target of Sun Pharma Advanced Research Company Ltd in 2029?

Sun Pharma Advanced Research Company Ltd share price target for 2029 is projected to reach ₹189.74 by year-end (range: ₹185.91 to ₹197.82), representing a -7.89% decrease from the current price of ₹206.00.

Should I buy Sun Pharma Advanced Research Company Ltd stock now?

Based on current analysis, Sun Pharma Advanced Research Company Ltd currently receives a hold research stance from this valuation framework. Intrinsic value is ₹201.31 vs CMP ₹206.00. Use this as a research input and match it with your risk profile, investment horizon and portfolio plan.

What is the fundamental floor price for Sun Pharma Advanced Research Company Ltd?

The fundamental floor price for Sun Pharma Advanced Research Company Ltd is ₹4.12, calculated from book value and financial strength metrics (ROE, ROCE, debt-to-equity, interest coverage). This is a modelled reference level rather than a guaranteed minimum, and the market price can trade below it.

Want to understand our prediction methodology?
Learn how Getaka’s forecasting method works →

Sun Pharma Advanced Research Company Ltd Share Price Prediction – How We Calculate the Targets

We calculate the share price targets for Sun Pharma Advanced Research Company Ltd using a combined approach of Geometric Fractional Brownian Motion (GFBM) and the Exponential Moving Average (EMA) for trend analysis. This hybrid model incorporates historical price data, memory effects through the Hurst exponent, and dynamic regime shifts based on the stock's trends. Below are the detailed steps of how these projections are calculated.

Step 1: Calculate the Log Returns

The log returns measure the relative change in stock prices over time. It is calculated as follows:

$Log Return = \ln (\frac{S_{i}}{S_{i - 1}})$

Where:

S_i: Stock price at time i
S_i-1: Stock price at time i-1

The log returns are calculated for each consecutive pair of stock prices between the start date (September 24, 2024) and the end date (September 24, 2026).

535 valid data points from the historical price data in the period from September 24, 2024 to September 24, 2026 have been used for the calculations.

Step 2: Calculate the Exponential Moving Average (EMA)

The EMA is a weighted average of past prices that gives more importance to recent prices. It is calculated as follows:

$EMA = α \times P_{t} + (1 - α) \times {EMA}_{t - 1}$

Where:

α: Smoothing factor $\frac{2}{n + 1}$
P_t: Current stock price at time t
EMA_t-1: EMA from the previous time step

Step 3: Calculate the Drift (Average Growth Rate)

The drift is the average rate at which the stock price grows over time. It is calculated as the mean of the log returns:

$μ = \frac{1}{n} \sum_{i = 1}^{n} \ln (\frac{S_{i}}{S_{i - 1}})$

For Sun Pharma Advanced Research Company Ltd, the drift (average growth rate) is -0.01%.

Step 4: Calculate the Volatility

The volatility measures the extent of price fluctuations. It is calculated as the standard deviation of the log returns:

$σ = \sqrt{\frac{1}{n} \sum_{i = 1}^{n} {(\ln (\frac{S_{i}}{S_{i - 1}}) - μ)}^{2}}$

Step 5: Calculate the Hurst Exponent

The Hurst exponent measures the "memory" or persistence of the stock price movement. It is calculated as follows:

$H = \frac{\log (R / S)}{\log (n)}$

Step 6: Project Future Share Prices Using GFBM and EMA

The future price of the stock is projected using a combined model of Geometric Fractional Brownian Motion (GFBM) and Exponential Moving Average (EMA) for trend-based regime switching.

Step 7: Predicting Tomorrow's Stock Price for Sun Pharma Advanced Research Company Ltd

The next market-day price forecast uses price trend, volatility, valuation gap and regime adjustment. The displayed value is the median estimate, supported by a 10–90% uncertainty range.

Step 8: Projected Share Prices for the Next 10 Years

The projected share prices for the next 10 years are calculated using the combined GFBM and EMA model, taking into account historical growth, volatility, and market trends.

Conclusion

Our hybrid approach provides a realistic projection of share prices for Sun Pharma Advanced Research Company Ltd over the next 10 years by considering historical performance, volatility, market memory, and current trends.

Useful Calculators

Best Online SIP Calculator With Step Up And Inflation

Best Online SIP Calculator With Step Up And Inflation features. Learn about SIP benefits, how it works, and get answers to common SIP questi…

Open →

CAGR Calculator with Growth Bar and Pie Chart

CAGR Calculator (India): compute annualized growth from start & end value plus years—₹ support, clean formula steps, quick chart, mobile-fri…

Open →

Create Professional GST Invoice

Generate GST-compliant invoices online with ease. Create, print, and download professional Proforma GST invoices for free. Perfect for busin…

Open →

Financial Calculators

Free financial calculators for Indian investors—SIP, CAGR, XIRR, RD, SWP, loans & more. Fast, privacy-first tools that run in your browser.

Open →

FIRE Calculator (India) – Retirement Corpus, Age & SIP Planner

Calculate your FIRE corpus in India with tax-adjusted returns, age tracking, SIP step-up, SWR, inflation, and a post-FIRE sustainability tes…

Open →

GST Calculator

Free GST Calculator to calculate GST, CGST, SGST & IGST for goods & services in India. Print or download invoices instantly. Easy, a…

Open →

Home Loan Prepayment Calculator with EMI & Tax Benefits

Maximize your savings with Getaka’s Home Loan Prepayment Calculator. Easily plan optimal EMIs and extra prepayments for home, car, and perso…

Open →

Intrinsic Value Calculator: DCF, Graham, DDM, PEG & Asset-Based Methods

Calculate stock intrinsic value using 5 valuation methods (DCF, Graham, DDM, Asset-Based & PEG). Get weighted average value, margin of safet…

Open →

Monte Carlo Retirement Calculator

Use our Monte Carlo Retirement Calculator to project 5000 possible retirement scenarios. Analyze portfolio growth, success probabilities, an…

Open →

Online XIRR Calculator: Your Key to Smarter Investment Decisions

Online XIRR Calculator (India): compute annualized returns from irregular cash flows—SIP, lumpsum & redemptions. ₹ support, Excel-style accu…

Open →

Position Size Calculator India – Risk, Stop Loss & Charges

Indian position size calculator for Equity (intraday/delivery) & F&O. Get quantity, margin, breakeven, and full brokerage + STT/GST charges …

Open →

Present Value (PV) Negotiation Calculator: Future Price → Present Price

Discount a seller’s asking price (or future-justified price) to today’s fair value. Enter years and discount rate to get present value (PV),…

Open →

Quantum Retirement Calculator India

Quantum Retirement Calculator for India: model your corpus with probability bands, inflation, SIP/SWP, and tax in ₹. Find how much to invest…

Open →

RD Calculator: Check Maturity & Interest Online ₹

Free RD calculator for India: maturity value, interest earned, post-tax returns and inflation-adjusted value. Includes bank-style quarterly …

Open →

Reverse CAGR Calculator: Empowering Investors with Strategic Financial Planning

Reverse CAGR Calculator (India): Instantly find the starting value from your final amount, CAGR% and years—₹ support, clear formula steps, a…

Open →

SWP Calculator (India) – Systematic Withdrawal Plan with Tax & Inflation

Free SWP Calculator for India. Estimate monthly withdrawals, corpus balance, total withdrawn and growth with return rate, time period and ta…

Open →

Sun Pharma Advanced Research Company Ltd Intrinsic Value & Analysis

Browse All Share Price Targets

All Stock Fundamental Analysis Reports

How to assess Sun Pharma Advanced Research Company Ltd share price targets

Compare the growth and valuation assumptions with reported profitability, debt and operating cash flow. A higher projected price needs supporting business performance; weaker earnings or a lower valuation multiple can produce a different outcome.

Start with Sun Pharma Advanced Research Company Ltd fundamentals and financial statements, then review what the P/E ratio measures and alternative intrinsic-value methods.

Research basis & forecast validation

Data as of: 24 Sep 2026 · Analysis owner: Getaka · Method: Getaka quantitative valuation + GFBM/EMA forecasting.

Historical forecast validation: 239 aligned forecasts · MAPE 6.31% · direction accuracy 52.7%.

Targets are model outputs, not promises. The page should be read together with valuation, profitability, balance-sheet risk, volatility and forecast-error information. Read the forecasting methodology.

Compare Miscellaneous share price targets →

Disclaimer

The projected stock prices are informational estimates based on available data and assumptions. Past performance does not guarantee future results. Investors should consider risk profile, investment horizon, portfolio allocation and market risks before acting on any research output. Please read all relevant documents and terms carefully before investing.